Company Overview - Xinli Financial closed at 9.8 yuan, up 2.40%, with a rolling PE ratio of 142.88 times and a total market value of 5.025 billion yuan [1] - The company ranks 19th in the multi-financial industry, which has an average PE ratio of 72.48 times and a median of 27.97 times [1] - As of the first quarter of 2025, six institutions held shares in Xinli Financial, with a total holding of 146.5244 million shares valued at 1.451 billion yuan [1] Business Operations - Xinli Financial's main business includes financing leasing, microloans, software and information technology services, pawn services, financing guarantees, and supply chain services [1] - The company's primary products are financing leasing, microloans, pawn services, software and information technology services, financing guarantees, online lending information intermediary services, and supply chain services [1] - The company has been awarded the title of "Innovative Case of Sci-tech Leasing in the Yangtze River Delta" [1] Financial Performance - In the latest financial report for the first quarter of 2025, Xinli Financial achieved an operating income of 89.8757 million yuan, a year-on-year increase of 7.13% [1] - The net profit for the same period was 17.4284 million yuan, reflecting a year-on-year growth of 29.83% [1] - The sales gross margin stood at 81.55% [1]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Xinli Financial, which has a current stock price of 9.69 yuan and a rolling PE ratio of 141.27 times, significantly higher than the industry average of 73.21 times [1][2] - Xinli Financial's total market capitalization is reported at 4.968 billion yuan, ranking 19th in the multi-financial industry based on PE ratio [1][2] - As of March 31, 2025, Xinli Financial has 84,726 shareholders, an increase of 20,527 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1] Group 2 - The main business operations of Xinli Financial include financing leasing, microloans, software and information technology services, pawn services, financing guarantees, and supply chain services [1] - The latest quarterly report for Q1 2025 shows that Xinli Financial achieved operating revenue of 89.8757 million yuan, a year-on-year increase of 7.13%, and a net profit of 17.4284 million yuan, reflecting a year-on-year growth of 29.83%, with a gross profit margin of 81.55% [1]

序号股票简称PE(TTM)PE(静)市净率总市值(元)13新力金融133.84151.044.3647.07亿行业平均 64.0265.281.63205.53亿行业中值28.4222.601.60174.39亿1江苏金租11.8612.111.43356.23亿2陕国投 A12.6312.810.95174.39亿3越秀资本13.2914.391.08330.13亿4国网英大16.2218.161.29285.92亿5渤海租赁 16.6521.830.62197.29亿6浙江东方19.6121.991.31205.95亿7瑞达期货21.1421.622.8982.73亿8中油资本 22.1619.970.91929.19亿9南华期货28.4228.433.14130.19亿10永安期货40.5535.711.60205.38亿11中粮资本 41.3222.601.26273.50亿12海德股份58.2734.222.12112.98亿 6月18日，新力金融今日收盘9.18元，下跌2.34%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到133.84倍，总市值47.07亿元。 从行业市盈率排名来 ...

6月9日，国际医学今日收盘5.17元，上涨1.37%，最新市净率3.25，创13天以来新低，总市值115.86亿 元。 股东方面，截至2025年3月31日，国际医学股东户数109907户，较上次增加4413户，户均持股市值35.28 万元，户均持股数量2.76万股。 来源：金融界 最新一期业绩显示，2025年一季报，公司实现营业收入9.97亿元，同比-14.99%；净利润-106353858.88 元，同比-1.37%，销售毛利率5.21%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)8国际医学-45.34-45.593.25115.86亿行业平均 41.4247.583.52160.55亿行业中值44.3250.812.7559.92亿1润达医疗-298.01197.212.57109.02亿2何氏眼 科-154.96-134.851.9336.95亿3*ST生物-139.41-135.5311.4526.90亿4诚达药业-74.10-126.951.6735.68亿5普 瑞眼科-65.48-58.832.8159.92亿6皓宸医疗-57.81-69.536.8626.21亿7创新医疗-48.6 ...

5月15日，国际医学今日收盘5.2元，下跌1.33%，最新市净率3.29，总市值117.54亿元。 资金流向方面，5月15日，国际医学主力资金净流出609.47万元，近5日总体呈流入状态，5日共流入 936.34万元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)7国际医学-45.99-46.253.29117.54亿行业平均 37.7943.763.40151.99亿行业中值38.8551.492.7248.17亿1润达医疗-303.46200.812.62111.01亿2何氏眼 科-136.34-118.641.7032.51亿3*ST生物-121.10-117.739.9523.37亿4普瑞眼科-68.82-61.822.9562.97亿5诚达 药业-68.70-117.701.5433.08亿6皓宸医疗-50.22-60.405.9622.76亿8创新医疗-42.40-47.342.5244.48亿9金域 医学-36.70-37.582.08143.29亿10百诚医药-29.24-71.391.4737.65亿11迪安诊断-23.32-26.201.4393.62亿 来源：金融界 西安国际医 ...

5月13日，国际医学今日收盘5.29元，上涨2.52%，最新市净率3.35，创14天以来新低，总市值119.57亿 元。 截至2025年一季报，共有10家机构持仓国际医学，其中其他5家、基金4家、券商1家，合计持股数 75944.78万股，持股市值41.39亿元。 西安国际医学投资股份有限公司的主营业务是大健康医疗服务和现代医学技术转化应用。公司的主要产 品是医疗业、软件和信息技术服务业、其他社会服务业、商品流通业。公司及子公司荣膺多项荣 誉："2024届标杆医院研究成果社会办医·单体医院100强"、"海峡两岸及港澳社会办医院100强"、"首批 西部社会办医标杆医院"、"2024年度最佳投关奖"、"西安市三八红旗集体"、"现代服务业优秀企业"等 众多荣誉。 最新一期业绩显示，2025年一季报，公司实现营业收入9.97亿元，同比-14.99%；净利润-106353858.88 元，同比-1.37%，销售毛利率5.21%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)7国际医学-46.79-47.053.35119.57亿行业平均 38.5745.023.42152.74亿行业中值38.1250.592 ...

5月9日，新力金融今日收盘8.97元，下跌3.13%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到130.78倍，总市值45.99亿元。 从行业市盈率排名来看，公司所处的多元金融行业市盈率平均70.45倍，行业中值28.21倍，新力金融排 名第19位。 最新一期业绩显示，2025年一季报，公司实现营业收入8987.57万元，同比7.13%；净利润1742.84万 元，同比29.83%，销售毛利率81.55%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)19新力金融130.78147.584.2645.99亿行业平均 70.4536.591.37198.32亿行业中值28.2122.071.34174.52亿1九鼎投资-20.51-23.452.4262.91亿2*ST仁 东-17.65-6.766.4156.29亿3爱建集团-13.59-14.160.6375.20亿4翠微股份-10.67-10.233.4270.29亿5江苏金租 10.6110.831.28318.58亿6陕国投A12.4812.660.94172.34亿7越秀资本13.0114.081.05323.10亿8国网 ...

5月9日，国际医学今日收盘5.12元，下跌2.10%，最新市净率3.24，总市值115.73亿元。 序号股票简称PE(TTM)PE(静)市净率总市值(元)7国际医学-45.28-45.543.24115.73亿行业平均 38.0043.993.36149.92亿行业中值38.3648.452.6151.49亿1润达医疗-302.80200.382.61110.77亿2何氏眼 科-135.47-117.891.6932.30亿3*ST生物-113.75-110.589.3421.95亿4普瑞眼科-68.75-61.762.9562.91亿5诚达 药业-68.44-117.261.5432.95亿6皓宸医疗-50.22-60.405.9622.76亿8创新医疗-40.76-45.512.4342.76亿9金域 医学-36.41-37.282.06142.13亿10百诚医药-29.67-72.441.5038.21亿11迪安诊断-22.22-24.961.3689.18亿 来源：金融界 股东方面，截至2025年3月31日，国际医学股东户数109907户，较上次增加4413户，户均持股市值35.28 万元，户均持股数 ...